The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 association
Yoichi Nagata(The University of Texas MD Anderson Cancer Center), Mitsuyoshi Nakao(Kumamoto University), Toshiyoshi Fujiwara(Okayama University), Tamio Mizukami(Nagahama Institute of Bio-Science and Technology), Hirohisa Kato(Cardiovascular Institute Hospital), Yoichi Taya(National University of Singapore), Tadashi Anan(Kumamoto University), Tetsuo Yoshida(Kyowa Kirin (Japan)), Hideyuki Saya(The University of Texas MD Anderson Cancer Center)
Cited by 101
Related Papers
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
Long-term Consequences of Kawasaki Disease
|Circulation|1996|1.3k
Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter
|Nature Genetics|1999|559
Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury
|Journal of Clinical Investigation|1999|480
Fate of coronary aneurysms in Kawasaki disease: Serial coronary angiography and long-term follow-up study
|The American Journal of Cardiology|1982|461